183158-33-0

Basic information

• Product Name: ACENAPHTHENE-5-BORONIC ACID
• Synonyms: Acenaphthelene-5-boronicacid;BB-8189Acenaphthene-5-boronic acid;(1,2-dihydroacenaphthylen-5-yl)boronic acid
• CAS NO: 183158-33-0
• Molecular Formula: C₁₂H₁₁BO₂
• Molecular Weight: 198.03
• Product Categories: blocks;BoronicAcids;Aryl;Boronic Acids;Boronic Acids and Derivatives
• Mol File: 183158-33-0.mol
• Article Data: 3

Chemical Properties

• Melting Point: 270 °C(lit.)
• Boiling Point: 429.9°C at 760 mmHg
• Flash Point: 213.8°C
• Appearance: /
• Density: 1.28g/cm³
• Vapor Pressure: 3.74E-08mmHg at 25°C
• Refractive Index: 1.675
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 9.11±0.20(Predicted)
• CAS DataBase Reference: ACENAPHTHENE-5-BORONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: ACENAPHTHENE-5-BORONIC ACID(183158-33-0)
• EPA Substance Registry System: ACENAPHTHENE-5-BORONIC ACID(183158-33-0)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 183158-33-0(Hazardous Substances Data)

Usage

General Description

Acenaphthene-5-boronic acid is a chemical compound used in organic synthesis and pharmaceutical research. It is a boronic acid derivative of acenaphthene, which is a polycyclic aromatic hydrocarbon. The boronic acid group in this compound makes it a valuable reagent for Suzuki-Miyaura coupling reactions, which are widely used in the synthesis of complex organic molecules. Acenaphthene-5-boronic acid is also being studied for its potential applications in the development of novel drugs and agrochemicals. Its unique structure and reactivity make it an important building block for the creation of diverse chemical compounds with various applications.

InChI:InChI=1/C12H11BO2/c14-13(15)11-7-6-9-5-4-8-2-1-3-10(11)12(8)9/h1-3,6-7,14-15H,4-5H2

Upstream product

• 2051-98-1 5-bromoacenaphthene 
• 589-87-7 1,4-bromoiodobenzene 

Downstream Products

• 1092384-66-1 4-(1,2-dihydroacenaphthylen-5-yl)isoquinoline 
• 1190085-30-3 2-[1,2-dihydroacenaphthen-5-yl]benzyl alcohol 
• 1217313-35-3 methyl (Z)-2-(tert-butoxycarbonylamino)-3-(1,2-dihydroacenaphthylen-5-yl)but-2-enoate 
• 1217313-36-4 methyl (E)-2-(tert-butoxycarbonylamino)-3-(1,2-dihydroacenaphthylen-5-yl)but-2-enoate 
• 1217313-44-4 methyl (Z)-2-(tert-butoxycarbonylamino)-3,3-bis(1,2-dihydroacenaphthylen-5-yl)acrylate 
• 1217313-38-6 methyl (E)-2-(tert-butoxycarbonylamino)-3-phenyl-3-(1,2-dihydroacenaphthylen-5-yl)acrylate 
• 1217313-37-5 methyl (Z)-2-(tert-butoxycarbonylamino)-3-phenyl-3-(1,2-dihydroacenaphthylen-5-yl)acrylate 
• 38251-47-7 5-allyl-1,2-dihydroacenaphthylene 
• 1384526-58-2 gold(III)(C10H5(CH2CH2))(κ3-(2,6-((C6H3)t-Bu)2pyridine)) 
• 1268708-32-2 C₂₆H₃₂N₂ 
• 1315469-87-4 C₂₄H₁₅N 
• 1315469-85-2 C₂₄H₁₇N 
• 871320-08-0 5-(4-bromophenyl)acenaphthene 
• 1478097-94-7 C₂₈H₂₃N₂O₆P 

Relevant articles and documents

Anthracene derivative and organic electroluminescence device employing the same

An anthracene derivative with a specified asynmetrical type structure. An organic electroluminescence device which comprises at least one organic thin film layer including a light emitting layer sandwiched between a pair of electrode consisting of an anode and a cathode, wherein at least one of the organic thin film layer comprises the anthracene derivative. An organic electroluminescence device which emits blue light of enhanced purity and has a long lifetime is provided.

Substituted phenyl farnesyltransferase inhibitors

Compounds of formula (I) or pharmaceutically acceptable salts thereof, inhibit farnesyltransferase. Methods for making the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.